Indoles and their therapeutic use
Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein the bond marked with an asterisk is attached to Ar1; R1 is hydrogen, fluoro, chloro, CN or CF3; R2 is hydrogen, fluoro or chloro; R3 is hydro...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
12.03.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein the bond marked with an asterisk is attached to Ar1; R1 is hydrogen, fluoro, chloro, CN or CF3; R2 is hydrogen, fluoro or chloro; R3 is hydrogen, C1C8alkyl or C3-C7cycloalkyl; Ar1 is phenyl or a 5- or 6-membered heteroaryl group selected from furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms; and Ar2 is phenyl or 5- or 6-membered heteroaryl group selected from pyrrolyl, furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms. |
---|---|
AbstractList | Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein the bond marked with an asterisk is attached to Ar1; R1 is hydrogen, fluoro, chloro, CN or CF3; R2 is hydrogen, fluoro or chloro; R3 is hydrogen, C1C8alkyl or C3-C7cycloalkyl; Ar1 is phenyl or a 5- or 6-membered heteroaryl group selected from furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms; and Ar2 is phenyl or 5- or 6-membered heteroaryl group selected from pyrrolyl, furanyl, thienyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, pyridinyl, pyridazinyl, pyrimidinyl and pyrazinyl, wherein the phenyl or heteroaryl groups are optionally substituted by one or more substituents independently selected from fluoro, chloro, CN, C3-C3-C7cycloalkyl, -O(C1-C4alkyl) or C1C6alkyl, the latter two groups being optionally substituted by one or more fluoro atoms. |
Author | ARIENZO ROSA FINCH HARRY AVITABILE-WOO BARBARA MONTANA JOHN GARY DOMOSTOJ MATHIAS HYND GEORGE |
Author_xml | – fullname: ARIENZO ROSA – fullname: FINCH HARRY – fullname: MONTANA JOHN GARY – fullname: DOMOSTOJ MATHIAS – fullname: AVITABILE-WOO BARBARA – fullname: HYND GEORGE |
BookMark | eNrjYmDJy89L5WRQ9MxLyc9JLVZIzEtRKMlIzSwCkUWJBamlJZnJCqXFqTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JD402MLY0sTC2MzJyJgIJQASVScy |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US8394836B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US8394836B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:58:22 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US8394836B23 |
Notes | Application Number: US20080746104 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130312&DB=EPODOC&CC=US&NR=8394836B2 |
ParticipantIDs | epo_espacenet_US8394836B2 |
PublicationCentury | 2000 |
PublicationDate | 20130312 |
PublicationDateYYYYMMDD | 2013-03-12 |
PublicationDate_xml | – month: 03 year: 2013 text: 20130312 day: 12 |
PublicationDecade | 2010 |
PublicationYear | 2013 |
RelatedCompanies | ARIENZO ROSA PULMAGEN THERAPEUTICS (ASTHMA) LIMITED FINCH HARRY AVITABILE-WOO BARBARA MONTANA JOHN GARY DOMOSTOJ MATHIAS HYND GEORGE |
RelatedCompanies_xml | – name: ARIENZO ROSA – name: PULMAGEN THERAPEUTICS (ASTHMA) LIMITED – name: AVITABILE-WOO BARBARA – name: DOMOSTOJ MATHIAS – name: HYND GEORGE – name: MONTANA JOHN GARY – name: FINCH HARRY |
Score | 2.8822012 |
Snippet | Compound of formula (I) are ligands of the CRTH2 receptor, useful inter alia for treatment of inflammatory conditions. Wherein X is -SO2- or *-SO2NR3- wherein... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Indoles and their therapeutic use |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130312&DB=EPODOC&locale=&CC=US&NR=8394836B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVbG-WEFyW8xj07SHIORFFWyLbaS3kn0EeonFpPTvd7KktRe9LbuwL_hm5pudmQV4NnNksqiIaM6UokwISblrZQg8yS3Pyk0hdbTFqDdM2fvcnbdgucuF0XVCN7o4IiJKIN4rLa9Xv06sSMdWli98iV3fr8nMj4yGHdcC2bKNKPDjyTgah0YY-unUGH36aAewvtMLUFofoRXt1WCIv4I6KWV1qFGSczie4GRFdQEtVXTgNNx9vNaBk4_mvRubDfTKS3h6K3TxJYLUn2j3PjnInSLrUl0BSeJZOKS41mJ_rkU63e_KuYY20n11A0QNsppFSMYGgnHPzVxH9F2upDTRWLBlF7p_TnP7z9gdnNn6KweHWvY9tKuftXpAhVrxR30VWwB_enI |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2J9RpDcgnlsmvYQhLxItU2LTaS30M1uoJe0mBT_vpMlrb3obdmFfcE3M9_szCzAs5ojk0VFpOSEc4VkGVOoqS0ReIxqlparGRPRFlE_TMjbwly0YLXLhRF1Qr9FcUREVIZ4r4S83vw6sTwRW1m-0BV2rV-D2Pbkhh3XAlnTZc-x_dnUm7qy69rJXI4-bLQDyMDoOyitj9DCtmow-J9OnZSyOdQowRkcz3CyojqHFi-60HF3H6914WTSvHdjs4FeeQFPo0IUX5KQ-kvCvS8d5E5J25JfghT4sRsquFa6P1eazPe7Mq6gjXSfX4PEh8uaRTBChhmhlrk0jWxgUs6YisaCznrQ-3Oam3_GHqETxpNxOh5F77dwqotvHQxF0--gXX1t-T0q14o-iGv5AelDfWU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Indoles+and+their+therapeutic+use&rft.inventor=ARIENZO+ROSA&rft.inventor=FINCH+HARRY&rft.inventor=MONTANA+JOHN+GARY&rft.inventor=DOMOSTOJ+MATHIAS&rft.inventor=AVITABILE-WOO+BARBARA&rft.inventor=HYND+GEORGE&rft.date=2013-03-12&rft.externalDBID=B2&rft.externalDocID=US8394836B2 |